Anti-SARS-CoV-2 Spike Glycoprotein S1 (RBD) [EPR24852-174] - Human IgG1 (Chimeric),Abcam,AB323456

This human monoclonal chimeric antibody has been engineered from a RabMAb parent antibody ( ab283946 ). By necessity, some rabbit sequence is retained as part of the variable domain. When multiplexing with other rabbit-derived antibodies, using cross absorbed Fc-reactive secondary antibodies are recommended. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Human

Reactivity

SARS-CoV-2

Application

I-ELISA

Platform ID

BAB839908588

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-SARS-CoV-2 Spike Glycoprotein S1 (RBD) [EPR24852-174] - Human IgG1 (Chimeric)
Cat. No.AB323456
HostHuman
IsotypeIgG1
ReactivitySARS-CoV-2
ApplicationI-ELISA
ClonalityMonoclonal
Clone NumberEPR24852-174
Concentration0.5 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data See full target information SARS-CoV-2 Spike Glycoprotein S1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.